Sr One Capital Management

Latest statistics and disclosures from Sr One Capital Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are ACLX, CRSP, SPRY, ALMS, MLYS, and represent 84.53% of Sr One Capital Management's stock portfolio.
  • Added to shares of these 3 stocks: ALMS (+$26M), ENGN, KALA.
  • Started 3 new stock positions in ALMS, ENGN, KALA.
  • Sr One Capital Management was a net buyer of stock by $34M.
  • Sr One Capital Management has $319M in assets under management (AUM), dropping by -12.27%.
  • Central Index Key (CIK): 0001910264

Tip: Access up to 7 years of quarterly data

Positions held by Sr One Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Sr One Capital Management

Sr One Capital Management holds 9 positions in its portfolio as reported in the June 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Arcellx Common Stock (ACLX) 40.5 $130M 2.3M 55.19
 View chart
CRISPR Therapeutics Common Shares (CRSP) 17.7 $57M 1.0M 54.01
 View chart
ARS Pharmaceuticals Common Stock (SPRY) 10.7 $34M 4.0M 8.51
 View chart
Alumis Common Stock (ALMS) 8.2 $26M NEW 2.0M 13.30
 View chart
Mineralys Therapeutics Common Stock (MLYS) 7.4 $24M 2.0M 11.70
 View chart
Design Therapeutics Common Stock (DSGN) 6.8 $22M 6.5M 3.35
 View chart
Nkarta Common Stock (NKTX) 6.2 $20M 3.3M 5.91
 View chart
enGene Holdings Common Shares (ENGN) 1.5 $4.7M NEW 500k 9.43
 View chart
KALA Bio Common Stock (KALA) 1.0 $3.1M NEW 444k 7.09
 View chart

Past Filings by Sr One Capital Management

SEC 13F filings are viewable for Sr One Capital Management going back to 2021